Filing Details

Accession Number:
0001209191-19-023673
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-04 17:00:21
Reporting Period:
2019-04-03
Accepted Time:
2019-04-04 17:00:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1357874 Precision Biosciences Inc DTIL Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1771680 Ling Dung Tony Yao C/O Precision Biosciences, Inc.
302 E. Pettigrew Street, Suite A-100
Durham NC 27701
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-03 6,487 $15.42 158,003 No 4 P Indirect By ArrowMark Life Science Fund, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By ArrowMark Life Science Fund, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,450 Direct
Common Stock 4,450 Indirect By THB Iron Rose, LLC Life Science Portfolio
Footnotes
  1. The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $15.28 to $15.50, inclusive. The reporting person undertakes to provide to Precision BioSciences, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
  2. These securities are held of record by the ArrowMark Life Science Fund, LP (the "ArrowMark Fund"). ArrowMark Colorado Holdings LLC ("ArrowMark Colorado") is an investment advisor to the ArrowMark Fund. The reporting person is employed as a portfolio manager for ArrowMark Colorado and has direct voting and dispositive control over the shares held by the ArrowMark Fund. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
  3. These securities are held of record by the THB Iron Rose, LLC Life Science Portfolio (the "THB Fund"). ArrowMark Colorado is an investment advisor to the THB Fund. The reporting person is employed as a portfolio manager for ArrowMark Colorado and has direct voting and dispositive control over the shares held by the THB Fund. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.